[go: up one dir, main page]

WO2017196576A4 - Système et procédé d'évaluation du risque de maladie et traitement - Google Patents

Système et procédé d'évaluation du risque de maladie et traitement Download PDF

Info

Publication number
WO2017196576A4
WO2017196576A4 PCT/US2017/030438 US2017030438W WO2017196576A4 WO 2017196576 A4 WO2017196576 A4 WO 2017196576A4 US 2017030438 W US2017030438 W US 2017030438W WO 2017196576 A4 WO2017196576 A4 WO 2017196576A4
Authority
WO
WIPO (PCT)
Prior art keywords
sensor
analytes
risk score
sepsis
level
Prior art date
Application number
PCT/US2017/030438
Other languages
English (en)
Other versions
WO2017196576A1 (fr
Inventor
Rajiv Shah
Bradley Liang
Bahar SUTORIUS
Katherine Wolfe
Ellen MESSER
Shaun Pendo
Original Assignee
Percusense
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Percusense filed Critical Percusense
Priority to EP17733193.1A priority Critical patent/EP3454750A1/fr
Publication of WO2017196576A1 publication Critical patent/WO2017196576A1/fr
Publication of WO2017196576A4 publication Critical patent/WO2017196576A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/076—Permanent implantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412—Detecting or monitoring sepsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4842—Monitoring progression or stage of a disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6861—Capsules, e.g. for swallowing or implanting
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0204—Operational features of power management
    • A61B2560/0214—Operational features of power management of power generation or supply
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/06—Accessories for medical measuring apparatus
    • A61B2560/063—Devices specially adapted for delivering implantable medical measuring apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/06—Arrangements of multiple sensors of different types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Immunology (AREA)
  • General Business, Economics & Management (AREA)
  • Vascular Medicine (AREA)
  • Business, Economics & Management (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

L'invention concerne un appareil de détection précoce d'une septicémie chez un hôte. L'appareil comprend un premier capteur destiné à mesurer directement un taux de glycémie, un deuxième capteur destiné à mesurer directement un taux de lactate et un troisième capteur destiné à mesurer directement un taux d'oxygène tissulaire. Le premier capteur, le deuxième capteur et le troisième capteur sont tous insérés en un point d'entrée unique dans un espace sous-cutané de l'hôte de sorte qu'une corrélation prédéfinie entre le taux de glycémie, le taux de lactate, et le taux d'oxygène tissulaire signale les états pathologiques se rapportant à une septicémie.
PCT/US2017/030438 2016-05-13 2017-05-01 Système et procédé d'évaluation du risque de maladie et traitement WO2017196576A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP17733193.1A EP3454750A1 (fr) 2016-05-13 2017-05-01 Système et procédé d'évaluation du risque de maladie et traitement

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US201662336482P 2016-05-13 2016-05-13
US62/336,482 2016-05-13
US201662348806P 2016-06-10 2016-06-10
US62/348,806 2016-06-10
US201662353559P 2016-06-23 2016-06-23
US62/353,559 2016-06-23
US201662370226P 2016-08-02 2016-08-02
US62/370,226 2016-08-02
US201662383233P 2016-09-02 2016-09-02
US62/383,233 2016-09-02
US201662401481P 2016-09-29 2016-09-29
US62/401,481 2016-09-29
US201762443070P 2017-01-06 2017-01-06
US62/443,070 2017-01-06
US15/417,055 US10888281B2 (en) 2016-05-13 2017-01-26 System and method for disease risk assessment and treatment
US15/417,055 2017-01-26

Publications (2)

Publication Number Publication Date
WO2017196576A1 WO2017196576A1 (fr) 2017-11-16
WO2017196576A4 true WO2017196576A4 (fr) 2018-01-18

Family

ID=60266784

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/030438 WO2017196576A1 (fr) 2016-05-13 2017-05-01 Système et procédé d'évaluation du risque de maladie et traitement

Country Status (3)

Country Link
US (2) US10888281B2 (fr)
EP (1) EP3454750A1 (fr)
WO (1) WO2017196576A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11166799B2 (en) * 2017-05-19 2021-11-09 Maxim Integrated Products, Inc. Physiological condition determination system
EP3485801A1 (fr) * 2017-11-19 2019-05-22 Indigo Diabetes N.V. Dispositif de capteur intégré implantable
US11529053B2 (en) 2017-12-20 2022-12-20 PercuSense, Inc. System and method for disease risk assessment and treatment
US20210161441A1 (en) * 2018-04-17 2021-06-03 Steven B. Waltman Monitoring catabolism markers
WO2020081503A1 (fr) * 2018-10-15 2020-04-23 Adams Rhonda Fay Montre intelligente clinique d'adressage d'événements cardiaques indésirables
WO2020086895A1 (fr) * 2018-10-24 2020-04-30 Scivera LLC Procédé mis en oeuvre par ordinateur pour quantifier une évaluation de risque chimique
US20220125354A1 (en) * 2018-11-08 2022-04-28 Abbott Diabetes Care Inc. Physical fitness training systems and methods
JP7461952B2 (ja) * 2018-12-20 2024-04-04 ウマン センス アーベー 患者における脳卒中を検出する装置及び方法
EP3701857B1 (fr) * 2019-02-28 2023-10-04 Hill-Rom Services, Inc. Appareil de support de patient ayant appareil d'affichage de signes vitaux et de la septicémie
AU2020250828A1 (en) * 2019-03-29 2021-09-16 Mysugr Gmbh Computer-implemented method and system for determining a relative risk for lack of glycemic control for a plurality of patients, and computer program product
US11160503B2 (en) * 2019-04-23 2021-11-02 Fresenius Medical Care Holdings, Inc. Wearable continuous vascular access monitor
CN110442035A (zh) * 2019-08-22 2019-11-12 梅钟可 一种多通道人体信息采集分析智能家居系统
CN114845634A (zh) * 2019-12-26 2022-08-02 德克斯康公司 用于败血症风险评估的系统和方法
US20210366619A1 (en) * 2020-05-20 2021-11-25 Koninklijke Philips N.V. Recovery profile clustering to determine treatment protocol and predict resourcing needs
CA3178307A1 (fr) * 2020-06-08 2021-12-16 Erwin S. Budiman Systemes, dispositifs et procedes pour une meilleure precision de capteur d'analyte et une detection de defaillance de capteur d'analyte
GB2598568A (en) * 2020-09-01 2022-03-09 Clini Hub Ltd Patient monitoring device
US20220211331A1 (en) * 2021-01-04 2022-07-07 Medtronic, Inc. Detection of infection in a patient
WO2022146860A1 (fr) * 2021-01-04 2022-07-07 Medtronic, Inc. Détection d'une infection chez un patient
US20240242832A1 (en) * 2021-05-06 2024-07-18 Koninklijke Philips N.V. Late-onset neonatal sepsis predictions
US11831688B2 (en) * 2021-06-18 2023-11-28 Capital One Services, Llc Systems and methods for network security
US12326918B2 (en) * 2021-10-18 2025-06-10 Optum Services (Ireland) Limited Cross-temporal encoding machine learning models
US12327193B2 (en) 2021-10-19 2025-06-10 Optum Services (Ireland) Limited Methods, apparatuses and computer program products for predicting measurement device performance
US12229188B2 (en) 2022-05-17 2025-02-18 Optum Services (Ireland) Limited Machine learning techniques for generating disease prediction utilizing cross-temporal semi-structured input data

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5724983A (en) 1994-08-01 1998-03-10 New England Center Hospitals, Inc. Continuous monitoring using a predictive instrument
JP3647032B2 (ja) 2000-08-18 2005-05-11 シグナス， インコーポレイテッド 低血糖事象の予測のためのマイクロプロセッサーおよびデバイス
AUPR343401A0 (en) 2001-02-28 2001-03-29 Nguyen, Hung Modelling and design for early warning systems using physiological responses
US20030032871A1 (en) 2001-07-18 2003-02-13 New England Medical Center Hospitals, Inc. Adjustable coefficients to customize predictive instruments
US7022070B2 (en) 2002-03-22 2006-04-04 Mini-Mitter Co., Inc. Method for continuous monitoring of patients to detect the potential onset of sepsis
US8086323B2 (en) * 2003-09-23 2011-12-27 Medtronic Minimed, Inc. Implantable multi-parameter sensing system and method
DK1677668T3 (da) 2003-10-13 2010-10-25 Novo Nordisk As Apparat og fremgangsmåde til bestemmelse af en fysiologisk tilstand
CA2555807A1 (fr) 2004-02-12 2005-08-25 Biopeak Corporation Procede et appareil non invasifs permettant de determiner un parametre physiologique
US7097662B2 (en) * 2004-08-25 2006-08-29 Ut-Battelle, Llc In-vivo orthopedic implant diagnostic device for sensing load, wear, and infection
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US20060263839A1 (en) * 2005-05-17 2006-11-23 Isense Corporation Combined drug delivery and analyte sensor apparatus
WO2007010521A2 (fr) 2005-07-18 2007-01-25 Integralis Ltd. Appareil, procede et code lisible par ordinateur pour la prevision de l'apparition de maladies mettant potentiellement la vie en danger
US8795170B2 (en) 2005-11-29 2014-08-05 Venture Gain LLC Residual based monitoring of human health
US8016776B2 (en) 2005-12-02 2011-09-13 Medtronic, Inc. Wearable ambulatory data recorder
US20120095304A1 (en) 2005-12-15 2012-04-19 Cardiopulmonary Corporation System and Method for Determining a Patient Clinical Status
US8498879B2 (en) * 2006-04-27 2013-07-30 Wellstat Vaccines, Llc Automated systems and methods for obtaining, storing, processing and utilizing immunologic information of individuals and populations for various uses
US7941199B2 (en) 2006-05-15 2011-05-10 Masimo Laboratories, Inc. Sepsis monitor
WO2007142968A2 (fr) 2006-05-30 2007-12-13 The University Of North Carolina At Chapel Hill Procédés, systèmes et produits de programme informatique pour l'évaluation d'un patient dans une unité de soins intensifs en pediatrie
WO2008089282A2 (fr) * 2007-01-16 2008-07-24 Silver James H Capteurs destinés à détecter des substances indicatives d'accident vasculaire cérébral, d'ischémie, d'infection ou d'inflammation
US20090156911A1 (en) 2007-10-08 2009-06-18 Optiscan Biomedical Corporation Low draw volume analyte detection systems
US8412293B2 (en) 2007-07-16 2013-04-02 Optiscan Biomedical Corporation Systems and methods for determining physiological parameters using measured analyte values
WO2009036329A1 (fr) 2007-09-14 2009-03-19 Corventis, Inc. Moniteur multicapteurs pour patient conçu pour détecter une décompensation cardiaque imminente
EP2194847A1 (fr) 2007-09-14 2010-06-16 Corventis, Inc. Dispositif adhérent avec de multiples capteurs physiologiques
US20090149724A1 (en) 2007-12-05 2009-06-11 Massachusetts Institute Of Technology System and method for predicting septic shock
FR2924847B1 (fr) 2007-12-06 2014-08-29 Vigilio Procede et equipement de detection de situation critique d'un sujet
US20090163774A1 (en) 2007-12-20 2009-06-25 Sudeesh Thatha Managment and Diagnostic System for Patient Monitoring and Symptom Analysis
WO2009100133A1 (fr) * 2008-02-04 2009-08-13 University Of Virginia Patent Foundation Système, procédé et produit de programme d'ordinateur pour détecter des changements d'état de santé et un risque de maladie imminente
EP2257216B1 (fr) 2008-03-12 2021-04-28 Medtronic Monitoring, Inc. Prévision d'une décompensation d'insuffisance cardiaque sur la base du rythme cardiaque
US20100274102A1 (en) 2009-04-22 2010-10-28 Streamline Automation, Llc Processing Physiological Sensor Data Using a Physiological Model Combined with a Probabilistic Processor
US9060722B2 (en) 2009-04-22 2015-06-23 Rodrigo E. Teixeira Apparatus for processing physiological sensor data using a physiological model and method of operation therefor
EP2482715A1 (fr) 2009-09-30 2012-08-08 Healthwatch Ltd. Système de contrôle et d'alarme de santé sans interférence en continu
US8527449B2 (en) 2009-11-05 2013-09-03 Mayo Foundation For Medical Education And Research Sepsis monitoring and control
JP6159250B2 (ja) 2010-03-15 2017-07-05 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 患者の生存性を予測するためのシステムの制御方法およびプログラム
EP2575605A4 (fr) 2010-05-28 2015-01-21 Res Triangle Inst Int Appareil, système, et procédé de détection des symptômes d'une crise d'épilepsie
US9719842B2 (en) 2010-07-06 2017-08-01 Norman A. Paradis Method for the discovery, validation and clinical application of multiplex biomarker algorithms based on optical, physical and/or electromagnetic patterns
US8814792B2 (en) 2010-07-27 2014-08-26 Carefusion 303, Inc. System and method for storing and forwarding data from a vital-signs monitor
GB201018774D0 (en) 2010-11-05 2010-12-22 Learning Clinic The Ltd A system and method for monitoring the health of a hospital patient
US20120130201A1 (en) * 2010-11-24 2012-05-24 Fujitsu Limited Diagnosis and Monitoring of Dyspnea
ES2689151T3 (es) 2011-02-09 2018-11-08 The Charles Stark Draper Laboratory, Inc Sistema de electroencefalografía implantable e inalámbrico
JP6010558B2 (ja) 2011-03-01 2016-10-19 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 患者の悪化の検出
US10925580B2 (en) 2011-08-29 2021-02-23 Alexander Francis Castellanos 2002 Trust Mobile vascular health evaluation devices using doppler ultrasound and correlation of parameters to output recommendations to a wrist-mounted display
US10327714B2 (en) 2012-03-29 2019-06-25 Senseonics, Incorporated Analyte concentration alert function for analyte sensor system
US20140062717A1 (en) * 2012-08-31 2014-03-06 The University Of Iowa Research Foundation Method for RFID Communication Using Inductive Orthogonal Coupling For Wireless Medical Implanted Sensors and Other Short-Range Communication Applications
CN103778312B (zh) 2012-10-24 2017-05-10 中兴通讯股份有限公司 远程家庭保健系统
US20140236025A1 (en) 2013-02-15 2014-08-21 Michael L. Sheldon Personal Health Monitoring System
US10149617B2 (en) 2013-03-15 2018-12-11 i4c Innovations Inc. Multiple sensors for monitoring health and wellness of an animal
US20140350352A1 (en) 2013-05-23 2014-11-27 Children's Medical Center Corporation System and method of assessing stability of patients
US20150025329A1 (en) 2013-07-18 2015-01-22 Parkland Center For Clinical Innovation Patient care surveillance system and method
WO2015073459A1 (fr) * 2013-11-14 2015-05-21 Dexcom, Inc. Dispositifs et procédés de surveillance continue d'analyte
US20150148617A1 (en) 2013-11-27 2015-05-28 General Electric Company Method and system for selecting alarm reduction algorithm
US10490049B2 (en) 2013-12-10 2019-11-26 General Electric Company Systems and methods for identifying patient distress
US9968288B2 (en) 2014-03-26 2018-05-15 Eco-Fusion Systems and methods for predicting seizures
US20160143596A1 (en) 2014-04-16 2016-05-26 Xerox Corporation Assessing patient risk of an acute hypotensive episode with vital measurements
US20150342538A1 (en) 2014-06-03 2015-12-03 Welch Allyn, Inc. Custom early warning scoring for medical device
GB2532919B (en) 2014-10-24 2019-05-15 Cambridge temperature concepts ltd Monitoring physiology
GB2533774A (en) 2014-12-23 2016-07-06 Fertility Focus Ltd Data processing based on multiple inputs
US10653369B2 (en) 2014-12-23 2020-05-19 Intel Corporation Device for health monitoring and response
US20160220127A1 (en) 2015-02-03 2016-08-04 Covidien Lp Wellness or illness assessment system, method, and computer program product
WO2016133928A1 (fr) * 2015-02-17 2016-08-25 Massachusetts Institiute Of Technology Système et méthode de gestion de tâches de soins de septicémie

Also Published As

Publication number Publication date
US20210236065A1 (en) 2021-08-05
US10888281B2 (en) 2021-01-12
EP3454750A1 (fr) 2019-03-20
US20170325749A1 (en) 2017-11-16
WO2017196576A1 (fr) 2017-11-16

Similar Documents

Publication Publication Date Title
WO2017196576A4 (fr) Système et procédé d'évaluation du risque de maladie et traitement
US10426386B2 (en) Non-invasive blood glucose level measurement method and non-invasive blood glucose level measurement device
CN103561636B (zh) 发热检测装置
US9222951B2 (en) Calibration method for the prospective calibration of measuring equipment
CA2853236C (fr) Procede et/ou systeme de surveillance d'un analyte present dans plusieurs compartiments
US20080312859A1 (en) Method of Calibrating a System for Measuring the Concentration of Substances in Body and an Apparatus for Exercising the Method
EP2382556A4 (fr) Procédé et dispositif de détection d'atténuation de signal précoce à l'aide de mesures du glucose dans le sang
JP2012531947A5 (fr)
CN104887194A (zh) 一种生理指标的检测方法及装置
US20240006075A1 (en) Systems and methods for predicting and detecting post-operative complications
EP4417124A3 (fr) Appareil et procédés de sondage du fonctionnement d'un capteur de détection d'analyte continue et d'auto-étalonnage
US20220354398A1 (en) Device, system and method for non-invasive monitoring of physiological measurements
US9538943B1 (en) Blood glucose monitor and method of use thereof
CA2952759C (fr) Procede et dispositif de determination d'un taux de glucose de fluide corporel d'un patient et produit programme d'ordinateur
WO2021048190A3 (fr) Procédés et appareil de collecte d'informations, de détection d'erreur et de détermination de concentration d'analyte pendant une détection d'analyte en continu
EP3649942A1 (fr) Capteur optique, procédé de mesure de signal optique et appareil d'estimation de la concentration d'analytes dans le sang
CN106096231A (zh) 一种诊断类医疗器械自动校验系统及方法
Tonelli et al. Access flow in arteriovenous accesses by optodilutional and ultrasound dilution methods
CN107924715A (zh) 使用多个非侵入式传感器估计物质浓度
KR20210147236A (ko) 반려 동물의 건강을 진단하기 위한 시스템 및 방법
US11759128B2 (en) Method and apparatus for non-invasively monitoring analytes in domesticated animals
CN108226097A (zh) 凝血快速测试装置
Childs et al. Multi-parameter brain tissue microsensor and interface systems: calibration, reliability and user experiences of pressure and temperature sensors in the setting of neurointensive care
US20240423509A1 (en) Non-intrusive glucose measurement using smart ring with personal calibration
CN207923712U (zh) 一种凝血快速测试装置

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17733193

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017733193

Country of ref document: EP

Effective date: 20181213